Colombia Advances Bans on Surrogacy and Child Sex Changes
House and Senate panels clear first votes; lawmakers seek final passage by mid-December to shield women and minors.
Two bills aimed at protecting women and children cleared their first committee debates in Colombia’s Congress, chamber statements said on Nov. 19, 2026: one would ban all surrogacy, the other would prohibit surgical and hormonal sex-change treatments on minors.
Surrogacy ban advances in the House
The First Committee of the House of Representatives approved unanimously a measure that would end surrogacy nationwide. The chamber said the text now heads to a second debate in the full House. Its sponsors hope for final approval before Dec. 16, when the ordinary sessions of Congress end.
Representative David Cote of the Centro Democrático, the bill’s rapporteur for Bogotá, said the initiative “seeks to completely prohibit surrogacy, both commercial and altruistic.” Representative Luis Miguel López of the Conservative Party, the bill’s author, welcomed the vote and voiced confidence it would clear “the three remaining debates for the good of vulnerable women in our country.” He added that “with this practice the dignity of women is reduced to zero.”
The Catholic Church teaches that surrogacy violates the dignity of the child and the mother by separating procreation from the marital union and treating the human person as an object of contract. Lawmakers’ focus on protecting vulnerable women aligns with that concern for the integrity of motherhood and the rights of the unborn.
Senate panel backs ‘Laura’ law for minors
In the Senate, the Seventh Committee approved on first debate a bill to ban surgical and hormonal “gender affirmation” treatments for minors. Senator Andrés Forero of the Centro Democrático is the measure’s sponsor and rapporteur. The bill is titled “Laura, niños no experimento” ("Laura, children are not experiments"), named for a young woman who at 15 received a hasty gender-dysphoria diagnosis, underwent hormone treatments and masculinizing surgery, later regretted the psychological and physical effects, and sued those responsible.
Forero said that, as “a national endocrinologist has in fact acknowledged,” some children “since the age of nine have been or are being subjected to this type of treatment.” Given current scientific evidence, he argued, such a decision should be reserved for the age of majority and “not from the age of nine as is happening today.”
Presented at the end of August, the bill seeks to spare minors procedures with “potentially irreversible effects” that also harm mental health. It notes that the United Kingdom, Sweden, and Finland have already restricted or banned such treatments for minors.
Church teaching holds that the human person is created male or female and that medical interventions altering healthy sexual characteristics in minors raise grave questions of justice, informed consent, and the duty to protect the young from irreversible harm. The Senate text frames the issue in those protective terms rather than ideology.
Both measures still face further debates before they can become law. Their first-committee passage marks a concrete legislative push in Colombia to limit practices that instrumentalize women’s bodies and expose children to life-altering medical pathways before they can freely consent.